Negative regulation of acute inflammatory response

pathway activity — cross-omics
GO:0002674Cross-omicsPROTEIN-MS → DRUGCellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Negative regulation of acute inflammatory response pathway is significantly associated with the drug response of multiple features, with the BLOOD_Leukemia cohort showing a particularly strong set of associations.

The most reproducible pathway-associated features across cancer lineages are PD173074, UNC1215, and Luminespib, each associated with the pathway in up to 1 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The box plot shows the strongest association, PD173074 grouped by Negative regulation of acute inflammatory response-low versus -high activity in BLOOD_Leukemia.

Pathway-associated features by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner featureX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LeukemiaPD173074 →-0.610-0.343.011.00731
BLOOD_LeukemiaUNC1215 →-0.200-0.343.010.00731
BLOOD_LeukemiaLuminespib →-0.449-0.343.007.00731
BLOOD_Leukemia123829 →-0.955-0.343.018.00731
BLOOD_LeukemiaQuizartinib →+0.482+0.343.014.00731
BLOOD_LymphomaDasatinib →+1.066+0.297.021.02931
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

PD173074 by Negative regulation of acute inflammatory response activity — BLOOD_Leukemia

Box plot of PD173074 in Negative regulation of acute inflammatory response-low vs -high samples in BLOOD_Leukemia.

Explore this box plot interactively →

Exploration